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Apoptosis plays an important role in embryonic development. PNAS-4 has been demonstrated to induce apoptosis in several
cancer cells. In this study, we cloned Xenopus laevis PNAS-4 (xPNAS-4), which is homologous to the human PNAS-4 gene.
Bioinformatics analysis for PNAS-4 indicated that xPNAS-4 shared 87.6% identity with human PNAS-4 and 85.5% with mouse
PNAS-4. The phylogenetic tree of PNAS-4 protein was also summarized. An analysis of cellular localization using an EGFP-
fused protein demonstrated that xPNAS-4 was localized in the perinuclear region of the cytoplasm. RT-PCR analysis revealed
that xPNAS-4, as a maternally expressed gene, was present in all stages of early embryo development. Whole-mount in situ
hybridization showed that xPNAS-4 was mainly expressed in ectoderm and mesoderm. Furthermore, microinjection of xPNAS-4
mRNA in vivo caused developmental defects manifesting as a small eye phenotype in the Xenopous embryos, and as a small eye
or one-eye phenotype in developing zebraﬁsh embryos. In addition, embryos microinjected with xPNAS-4 antisense morpholino
oligonucleotides (MOs) exhibited a failure of head development and shortened axis.
1.Introduction
Apoptosis,whichprotectsorganismsbyremovingpotentially
damaged cells and unnecessary cells after diﬀerentiation,
is a widely occurring phenomenon in animal development
[1]. Recently, reports about apoptosis during embryonic
development in various model organisms have ﬂourished.
Apoptosis occurs in blastocyst cavitation and continues
during gastrulation in mammal and chicken cells [2, 3].
Increased caspase-like activity and DNA fragmentation
occurs in Xenopus laevis (X. laevis) embryos at the gastrula
stage [4, 5]. Stress-induced apoptosis has also been char-
acterized in zebraﬁsh embryos [6]. Moreover, studies have
revealed that apoptosis may contribute to development of a
variety of organs such as brain, heart, lungs, and kidneys [7–
10].
X. laevis is considered as one of the most important
model organisms for studying vertebrate development and
diseases. In contrast with mouse embryos, the large and
robust X. laevis embryos are accessible in the stages during
which most important decisions of development are taken so
that a large variety of methodologies can be used to analyze
the genetic regulation of many diﬀerent developmental
processes.
PNAS-4 was previously identiﬁed as a novel apoptosis-
related protein in human acute promyelocytic leukemia NB4
cells. Recently, a report showed that the human PNAS-
4 gene was activated during the early response to DNA
damage [11]. In our previous studies, we proved that the
overexpression of PNAS-4 induced cancer cell apoptosis
via the activation of a mitochondrial pathway [12]. The
potential antitumor eﬀects of human PNAS-4 were also2 Journal of Biomedicine and Biotechnology
demonstrated[13,14].Tounderstandthebiologicalfunction
of the PNAS-4 gene in development, we ﬁrst cloned the
homologous PNAS-4 gene from X. laevis based on PNAS-4
bioinformatics analysis. In the present work, we addressed
the preliminary functional annotation of X. laevis PNAS-
4 (xPNAS-4) including protein sequence characterization,
subcellular localization, gene expression proﬁles in develop-
ing embryos, and the impacts of microinjection of xPNAS-4
mRNA or antisense morpholino oligonucleotides (MOs) on
embryonic development. Our primary studies on xPNAS-4
showed that xPNAS-4 may play important roles in embryo
development.
2.MaterialsandMethods
2.1. Cell Lines and Animal Models. The HEK (Human
embryonic kidney) 293 epithelial cell line was purchased
from ATCC. Female Xenopus laevis were injected with
300–500IU human chorionic gonadotropin (hCG) on the
evening before egg collection. Nine to 12 hours after
injection, eggs were collected and transferred into a fresh
petri dish with culture medium. Staging of embryos was per-
formed according to Nieuwkoop and Faber [15]. Zebraﬁsh
embryos were obtained and maintained as described in the
zebraﬁsh book [16].
2.2. Identiﬁcation of xPNAS-4 cDNA and Plasmid Con-
structs. The Xenopus homolog of PNAS-4 (xPNAS-4) was
identiﬁed in silico by blasting the X. laevis database with
the full-length sequence of the human PNAS-4 protein
(GenBank protein id NP 057160). The cDNA of xPNAS-
4 gene (GenBank accession no.BC087412) was ampliﬁed
using the primer combination 5 -GGATCCATGGCCAA-
CCAGCCCATCATC-3  and 5 -CTCGAGCTATAGTTTTG-
TGTGGCGCCCAGG-3 . RT-PCR ampliﬁcation was carried
out in a MyCycler thermal cycler (Bio-Rad) using the
following program: reverse transcription at 50
◦Cf o r4 0
minutes, and denaturing at 94
◦Cf o r2m i n u t e s ,f o l l o w e db y
a standard touchdown PCR regime of 94
◦C for 30 seconds,
60
◦C for 30 seconds, and 72
◦C for 40 seconds (15 cycles,
−1◦C/cycle), and 94
◦C for 30 seconds, 48
◦C for 30 seconds,
and 72
◦C for 40 seconds (35 cycles). The PCR product was
cloned directly into the pGEM-T easy vector (Promega) to
obtain pGEM-T-xPNAS-4 plasmid. DNA sequencing was
performed by BigDye Terminator Cycle sequencing and
the sequences were obtained with a 3730 DNA Analyzer
(Applied Biosystems). In order to construct the pEGFP-N1-
xPNAS-4plasmid,thefollowingprimerswereused,thesense
primer: 5 -CCGCTCGAGATGGCCAACCAGCCCATCA-3 
and the antisense primer: 5 -CGGGATCCCGTAGTTTT-
GTGTGGCGCCCAG-3 , containing the Xho Ia n dBamHI
restriction sites (underlined), respectively. The termination
codon was removed to be in-frame with the enhanced
green ﬂuorescent protein (EGFP) sequence. The following
ampliﬁcation procedure was applied: initial PCR activation
step at 94
◦C for 4 minutes, 35 PCR ampliﬁcation cycles
at 94
◦C for 30 seconds, 55
◦C for 30 seconds, 72
◦Cf o r
40 seconds and a ﬁnal extension cycle of 72
◦Cf o r1 0
minutes.
2.3. Bioinformatics. Nucleotide sequence and conserved
domain analysis were carried out using BLAST programs
(http://www.ncbi.nlm.nih.gov/blast/). Alignment of amino
acid sequences was constructed using the Clustal W
method (http://www.ebi.ac.uk/clustalw/)[ 17]. Homology
analysis and molecular evolutionary analysis were gener-
ated using Lasergene Software and the MegAlign program
(DNASTAR).
2.4. RT-PCR Analysis. Semiquantitative RT-PCR analysis
of xPNAS-4 expression was performed using the above-
mentioned primers. As an internal control for RNA qual-
ity, the housekeeping gene ornithine decarboxylase (ODC)
was also ampliﬁed with sense primer 5 -GTCAATGAT-
GGAGTGTATGGATC-3  and antisense primer 5 -TCC-
ATTCCGCTCTCCTGAGCAC-3  according to published
document [18]. Both reactions were ampliﬁed by using the
same number of extension cycles (30 cycles). The samples
were resolved on a 1.5% agarose gel with 1μg/mL of
ethidium bromide, and analyzed in a UV-Transilluminator
mini darkroom using Quantity One Software (Bio-Rad).
2.5. In Situ RNA Hybridization. Whole-mount in situ
hybridizations were performed according to the method of
Harland [19]. Digoxigenin-rUTP-labeled antisense probes
for xPNAS-4 were synthesized from pGEM-T-xPNAS-4
plasmid via Sp6 RNA polymerase. Hybridized transcripts
were visualized in situ with antidigoxigenin antibodies and
photographed using a Nikon dissecting microscope with an
attached camera.
2.6. Cellular Localization. 5 × 105 HEK293 cells which had
been grown in DMEM culture medium containing 10%
FBS, 100units/mL penicillin, and 100mg/mL streptomycin
were seeded on 6-well plates in a 37
◦C incubator with
5% CO2. Transfections were performed according to the
manufacturer’s recommendations by using 10μLo fl i p o -
fectamine 2000 (Invitrogen) and either 4μg of pEGFP-
N1 or pEGFP-N1-xPNAS-4 plasmid DNA. The culture
mediumwaschangedafter6hourswithgrowthmediumand
maintained for another 24 hours to allow expression of the
fusion protein. The transfected cells were examined under a
Zeiss Axiophot ﬂuorescence microscope.
2.7. In Vitro Transcription and Microinjection. Capped
mRNAsusedformicroinjectioninvitrowereproducedusing
an mMessage mMachine kit (Ambion). The reaction was
set up in a total volume of 50μL containing 2.5μg Xho
I—linearized pGEM-T-xPNAS-4 plasmid, 1×transcription
buﬀer, 0.5mM dNTPs, 2.5mM RNA cap structure analogue,
10mM DTT, 20U RNAsin, and 40U T7 RNA polymerase,
and then incubated for 2 hours at 37
◦C. The templates were
digested with 10U of RNase free DNase I by incubating the
samples for 30 minutes at 37
◦C. The volume was increased
with RNase free water to 100μL, and then the samples were
applied on Quick spin columns (Ambion) to purify the
products. Xenopus embryos at the one-cell stage were used
for microinjection.Journal of Biomedicine and Biotechnology 3
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Figure 1: Comparison of the PNAS-4 protein sequence from X. laevis (GenBank protein id: AAH87412) with those of other species. (a)
Alignment of xPNAS-4 and hPNAS-4 protein sequences (GenBank protein id: NP 057160) showing that they are homologous proteins.
There is a DUF862 domain (underlined) in the hPNAS-4 and xPNAS-4 proteins. Asterisks (∗) indicate amino acid residues that are
conserved across species. Colons (:) indicate strong similarity between protein xPNAS-4 and hPNAS-4. Dots (·) indicate weak similarity. (b)
Phylogenetic tree of the PNAS-4 nucleotide sequences.
2.8. Whole-Mount TUNEL Staining. Published procedures
for the whole-mount TUNEL staining of embryos were
followed [20]. In brief, embryos were ﬁxed overnight at 4◦C
in a 4% solution of formaldehyde in PBS. The samples were
washed twice in 100mM Tris-HCl buﬀer, pH 7.5, containing
150mM sodium chloride and 0.1% Tween 20 (TBST), and
ﬁxed in methanol at −20
◦C for an additional 24 hours. The
samples were washed three times at room temperature for
15 minutes in TBST to rehydrate the embryos following
methanol ﬁxation. The samples were transferred to TUNEL
buﬀer(25mMTris-HCl,pH6.6,containing200mMsodium
cacodylate, 5mM cobalt chloride, and 0.25% bovine serum
albumin),andwashedfor30minutes.Fluorescentlabelingof
fragmentedDNAinthesampleswascarriedoutfor1hourat
37
◦C in TUNEL buﬀer containing 1mM ﬂuorescein-dUTP
and 50units/mL terminal deoxynucleotidyl transferase. The
reaction was stopped by washing the sample in TBST
buﬀer ﬁve times for 5 minutes at room temperature. The
ﬂuorescein-labeledTUNEL-positivecellswerephotographed
usinganOlympusmicroscopewithexcitationat460–490nm
and emission at 510nm.
2.9. Morpholino Oligonucleotides and Microinjections. All
antisensemorpholinooligonucleotides(MOs)weredesigned
and supplied by Gene Tools Co. of America. MOs used
in this study were as follows: xPNAS-4 MO (5 -TCTCCT-
CCTCCTCCTGAGAATATCC-3 ), and Control MO (5 -
CCTCTTACCTCAGTTACAATTTATA-3 ). Both xPNAS-
4 MO and control MO were diluted to be 5ng/nL and
stored at −80
◦C in aliquots. Microinjection was performed
in 1-MMR containing 5% ﬁcoll (Sigma) solution. MOs
were microinjected into the animal blastomere of stage-
2 embryos. For rescue experiments, RNA and MOs were
premixed. Co-injection was performed at two diﬀerent
ratios: 20ng xPNAS-4 MO plus 450pg xPNAS-4 mRNA and
20ng xPNAS-4 MO plus 900pg xPNAS-4 mRNA.
3. Results and Discussion
3.1. Bioinformatics. By blasting the X. laevis database with
a human full-length PNAS-4 protein sequence (GenBank
protein id: NP 057160), we found an X. laevis PNAS-4
homologue (GenBank protein id: AAH87412)w h i c hw e
named xPNAS-4. The xPNAS-4 cDNA sequence contains an
open reading frame of 579bp encoding 192 amino acids.
Just like the human PNAS-4 protein, xPNAS-4 contains
a putative DUF862 conserved domain corresponding to
amino acid residues 4 to 131 (Figure 1(a)). The sequence of
xPNAS-4 protein was compared with those of other species
including Bos Taurus (GenBank protein id. XP 597874),4 Journal of Biomedicine and Biotechnology
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Figure 2: Cellular localization, and temporal and spatial expression patterns of xPNAS-4. (a) HEK293 cells were transfected with pEGFP-
N1 or pEGFP-N1-xPNAS-4 plasmids as explained in materials and methods. Left: pEGFP-N1 transfected cells (200×); Right: pEGFP-N1-
xPNAS-4 transfected cells (200×). (b) Analysis of the temporal expression pattern of xPNAS-4 gene by semiquantitative RT-PCR. ODC:
X. laevis ornithine decarboxylase as internal control gene. RT (–): control reverse transcription without template. (c) Whole mount in situ
hybridizations showing the spatial expression pattern of xPNAS-4 gene. The upper-left image shows the expression pattern of the xPNAS-
4 gene in a stage-2 embryo. The upper-right image shows the expression pattern of the xPNAS-4 gene in a stage-10 embryo (beginning of
gastrulation). An ubiquitous expression pattern (purple staining) can be seen. The lower image shows the expression pattern of the xPNAS-4
gene at stage 35. xPNAS-4 transcripts were present in the head, dorsal neural tissue, and prospective heart.
Pongo pygmaeus (GenBank protein id: Q5R456), Homo
sapiens (GenBank protein id: NP 057160), Gallus gallus
(GenBank protein id: NP 001008460), Danio rerio (Gen-
Bank protein id: NP 001003532), Rattus norvegicus (Gen-
Bank protein id: AAH83584), and Mus musculus (GenBank
protein id: Q9D291), the identity was 88.1%, 87.6%, 87.6%,
87.0%, 86.0%, 85.5%, and 85.5%, respectively. This con-
ﬁrmed that these genes share a common ancestor. Based
on the homology analysis, a phylogenetic tree of PNAS-4
proteins was constructed (Figure 1(b)).
3.2. Cellular Localization of xPNAS-4. To examine xPNAS-4
cellular localization, we fused xPNAS-4 to EGFP. Expression
of xPNAS-4-EGFP in HEK293 cells appeared in the cyto-
plasmandwascloselylocatedaroundthenuclei,butthecon-
trol (EGFP) protein was evenly distributed throughout the
whole cell without any compartmentalization (Figure 2(a)).
Thus, xPNAS-4 was a cytoplasmic protein which was local-
ized in the perinuclear region of the cytoplasm.
3.3. Temporal and Spatial Expression of xPNAS-4 in X. Laevis
Embryos. In order to determine the temporal expression
pattern of xPNAS-4, the mRNA level at diﬀerent devel-
opmental stages was detected. Semiquantitative RT-PCR
analysis showed that xPNAS-4 mRNA could be detected at
all stages of development, from the unfertilized egg to the
tadpole stage (Figure 2(b)). The lowest expression level of
xPNAS-4 appeared at stage 8 (the mid-blastula transition).
Before the mid-blastula transition, the expression level of
xPNAS-4 decreased along with the rate of cell division.
After the mid-blastula transition, however, the expression
level of xPNAS-4 increased rapidly. This result suggests thatJournal of Biomedicine and Biotechnology 5
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Figure 3: Developmental defects in Xenopus embryos caused by microinjection of xPNAS-4. Embryos were injected once into the dorsal
marginal zone at the one-cell stage with 450pg or 900pg of xPNAS-4 mRNA. (a) Lateral view of stage 35 tadpoles showing (bottom to top)
an unaﬀected embryo (Wt, bottom); a mildly aﬀected embryo (Lae, middle) and a strongly aﬀected embryo (Sae, upper). Arrows indicate
embryos’ eyes. (b), (c), and (d) are magniﬁed views from local regions in the pictures. Abbreviations: Wt, wild type; Lae, mildly aﬀected
embryo; Sae, strongly aﬀected embryo; My, myotome; Pi, pigment. (e) Dorsal view of an uninjected stage 43 embryo. (f) Dorsal view of
stage 43 embryo which was injected with 900pg of xPNAS-4 mRNA. (g) Graphical representation of the percent of embryos injected with
xPNAS-4 mRNA with the small eye phenotype at stage 35 (n = the number of embryos in each group).
there is xPNAS-4 message of maternal origin, since zygotic
transcription starts at the mid-blastula transition (MBT)
[21]. Indeed, many other apoptosis-related genes showed
similar transcription patterns [22, 23]. Consequently,
xPNAS-4 may play an important role in Xenopus embryo
development.
For a better understanding of the expression of xPNAS-
4 mRNA in embryonic tissues, whole mount in situ
hybridizationwasperformed.Figure 2(c)showsthatxPNAS-
4 was mainly present along ectoderm and mesoderm. The
expression of xPNAS-4 could be detected at stage 2. This was
consistent with the result of semiquantitative RT-PCR. Up
to the gastrula stage (stage 10), the expression of xPNAS-
4 was present ubiquitously in the embryo. By the tail
bud stage (stage 35), the expression of xPNAS-4 mainly
appeared in the head and dorsal neural tissue. Furthermore,
a weak expression of xPNAS-4 could also be observed in
the prospective heart of the tail bud embryo. Thus, xPNAS-
4 is a maternally expressed gene. Its transcripts are present
ubiquitously in gastrula stage embryos, while tissue speciﬁc
expression can be detected in later embryogenesis.
3.4. Microinjections of xPNAS-4 mRNA Caused Develop-
mental Defects. To explore the role of xPNAS-4 during
embryonic development, the synthesized xPNAS-4 mRNA
was injected into Xenopus embryos at the one-cell stage. As
shown in Figures 3(a), 3(e), and 3(f), the eyes were poorly
developed and were smaller than normal. Some embryos
also showed defective myotomes and reduced pigmentation
(Figures 3(b)–3(d)). The abnormal eye phenotype was dose
dependent. About 26% small eye embryos were produced
by injection of xPNAS-4 mRNA at 450pg/embryo; while
about 38% small eye embryos were observed when xPNAS-4
mRNA was injected at 900pg/embryo. The uninjected
embryos only produced 2% eye abnormalities (Figure 3(g)).
This result demonstrated that xPNAS-4 plays an important
role in embryonic eye development.
Taking into consideration the high conservation of
xPNAS-4proteinwiththatofzebraﬁsh,wehypothesizedthat
xPNAS-4 would act in a similar manner in zebraﬁsh, another
developmental system used to study eye development [24].
To test this postulation, we injected xPNAS-4 mRNA into
zebraﬁsh embryos at the one-cell stage. The resulting
phenotype was quite similar to what occurred with xPNAS-
4 mRNA injection in Xenopus. Following injection of 300pg
xPNAS-4 mRNA 38% of embryos had abnormal eyes, and
after injection of 600pg mRNA 86% of embryos exhibited
abnormal eye development. Unlike Xenopus embryos, how-
ever, zebraﬁsh embryos with eye defects could be divided
into two groups: the less aﬀected embryos had reduced eye
size, while the more strongly aﬀected embryos exhibited
a one-eye phenotype (Figures 4(d), 4(e), and 4(h)). In
addition to the eye defect, some strongly aﬀected embryos
had a bent axis (Figures 4(f) and 4(i)). Similarly, the
defects produced by heterologous expression of xPNAS-4
were also dose dependent. Injection of 300pg of xPNAS-4
mRNA resulted in 34% reduced eye embryos and 4% one-
eye embryos, while injection of 600pg of xPNAS-4 mRNA
resulted in 24% reduced eye embryos and 62% one-eye
embryos (Figures 4(j)–4(l)). All of the uninjected embryos
were normal (Figures 4(a)–4(c), and 4(g)).
3.5. xPNAS-4 Induces Eye Developmental Defects Via Apop-
tosis. To conﬁrm that the developmental defects caused6 Journal of Biomedicine and Biotechnology
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Figure 4: Heterologous expression of xPNAS-4 causes eye defects in zebraﬁsh embryos. Embryos were injected at the one-cell stage with
300pg or 600pg of xPNAS-4 mRNA. Figures 4(a)–4(f) show embryos at 24 hours post fertilization (hpf). (a) Ventral view of a wild type
zebraﬁsh embryo with anterior to the bottom right. (b) Ventral view of a wild type zebraﬁsh embryo with anterior to the top. (c) Lateral
view of the normal axis of a wild type embryo. (d) Ventral view of a reduced-eye embryo. Arrow indicates the reduced eye. (e) Ventral view
of a one-eyed embryo with anterior to the top. Arrow indicates the lost eye. (f) Lateral view of bent axis defects (arrow) of xPNAS-4 mRNA
injected embryo. Figures 4(g)–4(i) show embryos at 48hpf with anterior to the top. (g) Dorsal view of a wild type zebraﬁsh embryo. (h)
Dorsal view of an embryo with a reduced size eye. (i) Dorsal view of a one-eyed embryo. (j) Population of wild type zebraﬁsh embryos
at 48hpf. (k) Population of zebraﬁsh embryos with eye defects at 48hpf. (l) Quantitative data for eye defects in injected and uninjected
zebraﬁsh embryos at 48hpf. N is the number of embryos examined for each treatment. (m) Whole-mount TUNEL staining of a wild type
embryo at 24hpf. (n) Whole-mount TUNEL staining of an embryo with an eye defect at 24hpf. A high number of TUNEL-positive cells
were detected on the side of injection (black arrow). Dotted circle indicates the developing eyes.Journal of Biomedicine and Biotechnology 7
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Figure 5: Eﬀect of xPNAS-4 MOs microinjection. (a) Embryos microinjected with 20ng of xPNAS-4 MO exhibited failure of head
development and shortened axis defects (left), but embryos microinjected with 20ng of control MO embryos were normal (right). (b) The
embryos were partially rescued by co-injected with 450pg of xPNAS-4 mRNA and 20ng of xPNAS-4 MO (the second row) in comparison
with embryos microinjected with 20ng of xPNAS-4 MO alone (the ﬁrst row). Better rescue was observed after co-injection of 20ng of
xPNAS-4 MO plus 900pg of xPNAS-4 mRNA (the third row). The fourth row shows a normal embryo microinjected with 20ng of control
MO. (c) The rate of defective embryos seen in the experiment.
by heterologous injection of xPNAS-4 resulted from apop-
tosis, whole-mount TUNEL (terminal deoxynucleotidyl
transferase-mediated nicked-end labeling) staining, a highly
sensitive indicator of DNA fragmentation in situ was
employed to detect the presence of apoptotic cells. TUNEL-
positive cells were present at high frequency on the side of
zebraﬁsh embryos on which eye development was aﬀected
(Figure 4(n)) when compared with the control embryos
(Figure 4(m)).
It is widely accepted that apoptosis is involved in
many embryological processes and plays a signiﬁcant role
in animal development. If apoptosis is disturbed, tissues
develop abnormally and various syndromes or cancers
develop [25]. The tumor suppressor protein p53, a widely
known trigger of apoptosis, has been implicated as an
important protein in embryonic development. Inappro-
priate overexpression or underexpression of p53 can lead
to embryonic lethality or increased risk of malformations
[26]. Furthermore, an eﬀect of apoptosis on eye develop-
ment has also well been documented. Inactivation of p53
function by gene knock-out [27] or through lens speciﬁc
promoter-driven expression of the viral gene E6, interrupts
normal apoptosis in the lens leading to formation of a
cataract [28, 29]. The caspase family including caspase-
1, -2, -3, -4, -6, and -9, is involved in eye diﬀerentiation
in diﬀerent species of vertebrates [30]. During develop-
ment of the chicken lens, members of the Bcl-2 family,
such as Bcl-2, Bax, Bad, and Bcl-Xs/l, are abundantly
expressed between stages E12 and E16 [31]. In our exper-
iment, we found a considerable number of apoptotic cells
appeared in abnormal embryos by whole mount in situ
hybridization, suggesting that abnormal eye development
resulted from the overexpression or heterologous expres-
sion of xPNAS-4. This further conﬁrmed that xPNAS-
4 is involved in apoptosis during embryonic develop-
ment.8 Journal of Biomedicine and Biotechnology
3.6. Depletion of xPNAS-4 Aﬀects the Normal Process
of Embryos. To further deﬁne the function of xPNAS-4
during embryogenesis, we performed translational inhibi-
tion of xPNAS-4 by microinjecting antisense morpholino
oligonucleotides (MOs). Control and xPNAS-4 MOs (20ng)
were microinjected into the animal blastomere of stage-
2 embryos. As development proceeded, 86.7% of embryos
(n = 98) microinjected with xPNAS-4 MO had a failure of
head development and a shortened axis (Figures 5(a) and
5(c)). All embryos which had a failure of head development
exhibited a shortened axis. Embryos with failed head devel-
opment died in the late tailbud stage, while control MO
microinjected embryos (98.4%, n = 128) developed to the
next stages normally.
In order to conﬁrm that the phenotypes were due to
translational inhibition of xPNAS-4, we co-injected xPNAS-
4 MO and in vitro transcribed capped xPNAS-4 mRNA. As
expected, the failure of head development and the shortened
axis were rescued to some extent after co-injection of 20ng
xPNAS-4 MO plus 450pg xPNAS-4 mRNA. About 56.5%
of embryos (n = 92) exhibited a failure of head develop-
ment. The defective embryos had longer axes than those
microinjected with xPNAS-4 MO alone. A greater extent
of rescue was observed after co-injection of 20ng xPNAS-
4 MO plus 900pg xPNAS-4 mRNA. Only 32.1% embryos
(n = 78) showed the failure of head development. The
defective embryos had longer axes than those microinjected
with xPNAS-4 MO plus 450pg xPNAS-4 mRNA (Figures
5(b) and 5(c)). These results revealed that the failure of head
development and shortened axis caused by xPNAS-4 MO
microinjection were due to depletion of xPNAS-4.
We also found similar defects using zebraﬁsh as a model
systeminourpreviousstudies.LossoffunctionofthePNAS-
4genecausedgastrulationdefectswith ashorterandbroader
axis, as well as a posteriorly mis-positioned prechordal plate,
due to the defective convergence and extension movement
[32]. In the present work, we found that loss of function
of the PNAS-4 gene in X. laevis embryos resulted in the
failure of head development and a shortened axis. The
phenotypic diﬀerences were probably due to the diﬀerent
species or diﬀerences in the inhibition rate of morpholino
oligonucleotides.
4. Conclusion
PNAS-4 protein is well conserved across species. Here
we identiﬁed the PNAS-4 homolog from X. laevis based
on the amino acid sequence of human PNAS-4 protein.
The xPNAS-4 protein is very similar to human PNAS-
4. The high similarity suggested that the human and X.
laevis proteins might have analogous functions. Cellular
localization suggested that xPNAS-4 is in the cytoplasm
and is located around the nucleus. We also proved that
xPNAS-4 is a maternally expressed gene. Investigation of
the developmental expression pattern showed that xPNAS-
4 is present throughout embryogenesis and undergoes
pronounced changes in its level of mRNA during embryo
development. In addition, microinjections of xPNAS-4
mRNA into Xenopus laevis embryos resulted in embryonic
developmental defects including a small eye phenotype in
developing X. laevis embryos, and a reduced eye size or
one-eye phenotype in the developing zebraﬁsh embryos.
Whole mount in situ hybridization further conﬁrmed that
the developmental defects resulted from apoptosis during
embryonic development. Furthermore, embryos microin-
jected with xPNAS-4 MO had a failure of head development
and shortened axis.
In conclusion, our results provide important clues about
the molecular mechanisms by which xPNAS-4 regulates
developmental processes.
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